跳至主要内容
临床试验/NL-OMON52962
NL-OMON52962已完成不适用

A prospective randomized controlled trial on the Systemic effects of bronchoscopic Lung Volume reduction in patients with severe Emphysema. - SOLVE study

niversitair Medisch Centrum Groningen0 个研究点目标入组 96 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
96

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - FEV1 <=45%pred AND FEV1/FVC <70%.
  • - TLC >100%pred AND RV>175%pred.
  • - CAT >=10.
  • - >50% emphysema destruction @-910HU.
  • - >95% complete major fissure measured by quantitative CT analysis.
  • - Non-smoking >6 months.
  • - Signed informed consent.

排除标准

  • - PaCO2>8.0 kPa, or PaO2<6.0kPa.
  • - 6-minute walk test <160m.
  • - Significant chronic bronchitis, bronchiectasis, or other infectious lung
  • - 3 or more hospitalizations due to pulmonary infection within last 12 months
  • before baseline assessments
  • - Previous lobectomy, LVRS, or lung transplantation.
  • - LVEF<45% and or RVSP>50mmHg.
  • - Anticoagulant therapy which cannot be weaned off prior to procedure.
  • - Patient is significantly immunodeficient.
  • - Involved in other pulmonary drug studies within 30 days prior to this study.
  • - Pulmonary nodule which requires intervention
  • - Any disease or condition that interferes with completion of initial or
  • follow-up assessments

研究者

相似试验